Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| Cytokinetics Inc. | 34 | 1 | 0 | 0 | €51.50 | €83.92 | 62.944% |
| Intra-Cellular Therapies Inc. | 31 | 0 | 1 | 0 | €70.50 | €83.92 | 19.036% |
| Gilead Sciences Inc | 11 | 1 | 1 | 0 | €69.61 | €85.27 | 22.503% |
| Ultragenyx Pharmaceutical Inc. | 24 | 1 | 3 | 0 | €41.20 | €92.48 | 124.459% |
| BioMarin Pharmaceutical Inc. | 16 | 0 | 1 | 0 | €76.86 | €102.54 | 33.414% |
| Abbott Laboratories | 19 | 0 | 2 | 0 | €101.36 | €116.25 | 14.688% |
| Merck & Co. Inc. | 33 | 1 | 4 | 0 | €105.60 | €125.72 | 19.052% |
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €133.50 | €130.00 | -2.622% |
| Neurocrine Bioscience | 39 | 0 | 8 | 0 | €139.60 | €149.47 | 7.072% |
| Repligen Corp. | 17 | 0 | 4 | 0 | €143.15 | €178.01 | 24.353% |
| Johnson & Johnson | 41 | 1 | 5 | 0 | €149.38 | €179.00 | 19.829% |
| AbbVie Inc. | 31 | 0 | 9 | 0 | €172.02 | €180.22 | 4.766% |
| Krystal Biotech | 17 | 0 | 0 | 0 | €173.70 | €185.58 | 6.839% |
| Zoetis Inc. A | 23 | 1 | 0 | 0 | €164.12 | €200.06 | 21.897% |
| Alnylam Pharmace. | 48 | 0 | 4 | 0 | €244.00 | €270.83 | 10.997% |
| Biogen Inc. | 52 | 2 | 5 | 1 | €188.50 | €289.80 | 53.739% |
| United Therapeutics | 25 | 1 | 4 | 1 | €295.30 | €290.24 | -1.714% |
| Amgen Inc. | 25 | 0 | 1 | 0 | €303.35 | €304.65 | 0.427% |